Dornase Alfa for ARDS in Patients With SARS-CoV-2

Conditions:   SARS-CoV 2;   ARDS Intervention:   Drug: Dornase Alfa Inhalation Solution Sponsor:   University of Missouri-Columbia Not yet recruiting

Source: ClinicalTrials.gov - May 27, 2020 Category: Research Source Type: clinical trials